1 year return (CAGR)
46.15%
Relmada Therapeutics Inc Exchange (NASDAQ, USD)
RLMD
3.23
-0.04 (-1.22%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
1.38%
5 year return (CAGR)
-32.52%
10 year return (CAGR)
-4.91%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
344.54M
Price/Sales
-
Ent value
345.71M
Price/Book
1.67
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.30 |
| Daily high | 3.31 |
| Daily low | 3.21 |
| Daily Volume | 776K |
| All-time high | 74.40 |
| 1y analyst estimate | 10.75 |
| Beta | 0.45 |
| EPS (TTM) | -0.55 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 24 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RLMD | S&P500 | |
| Current price drop from All-time high | -95.66% | -1.76% |
| Highest price drop | -99.66% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -78.93% | -10.65% |
| Avg time to new high | 190 days | 12 days |
| Max time to new high | 2885 days | 1805 days |
News
